B, A., XY, Z., CY, H., Z, G., & CH, J. (2026). Synthetic strategies for small molecule compounds for the treatment of Parkinson's disease: Targeting α-synuclein. Molecular diversity, 30(4), 5067. https://doi.org/10.1007/s11030-026-11510-9
Chicago Style (17th ed.) CitationB, Ai, Zhang XY, Hu CY, Guo Z, and Jin CH. "Synthetic Strategies for Small Molecule Compounds for the Treatment of Parkinson's Disease: Targeting α-synuclein." Molecular Diversity 30, no. 4 (2026): 5067. https://doi.org/10.1007/s11030-026-11510-9.
MLA (9th ed.) CitationB, Ai, et al. "Synthetic Strategies for Small Molecule Compounds for the Treatment of Parkinson's Disease: Targeting α-synuclein." Molecular Diversity, vol. 30, no. 4, 2026, p. 5067, https://doi.org/10.1007/s11030-026-11510-9.